Jefferies, BofA, Leerink, Guggenheim, Truist and LifeSci Capital acted as joint book running managers for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRUS:
- Merus’s Promising Clinical Developments and Market Potential Justify Buy Rating
- Closing Bell Movers: Guidewire up 11% after Q3 beat, guidance raise
- Merus announces common shares offering, no amount given
- Merus’s Strong Clinical Data and Financial Stability Justify Buy Rating
- Merus Announces Promising Phase 2 Trial Results